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One goal of the US$700 million Women’s Health 
Initiative Randomized Controlled Dietary Modification 
Trial (WHIRCDMT) was to determine whether post-
menopausal women who adopted what was regarded 
as a ‘heart healthy’ low-fat diet, high in vegetables, 
fruits and grains, reduced their risk of developing cardiovascular 
disease (CVD). The trial substantially favoured the outcome in the 
intervention group, who also received an intensive nutritional and 
behaviour education programme not offered to the control group. 
The conclusion after 8.1 years of study was that: ‘… a reduced total 
fat intake and increased intake of vegetables, fruits, and grains did 
not significantly reduce the risk of [coronary heart disease] (CHD), 
stroke, or CVD in postmenopausal women and achieved only modest 
effects on CVD risk factors’ (p. 655).[1] However, the abstract notes 
that these conclusions apply only to women who were healthy at 
the start of the trial since it excludes ‘participants with baseline 
CVD (3.4%)’. It is not clear whether the inclusion of these unhealthy 
women would have altered the overall conclusion. 
The study’s only statistically significant finding, reported on the 
seventh page of the published manuscript (p. 661),[1] has yet to enter 
the scientific discourse: ‘The H(azard)R(atio) for the 3.4% of women 
with CVD at baseline was 1.26 (95% CI, 1.03-1.54)’. 
This shows that women with diagnosed CVD at the start of the 
trial who adopted the ‘healthy heart’ low-fat eating option had a 
risk of developing future cardiovascular complications that was 26% 
higher than that of the non-intervention group. This finding is not 
discussed and a key line of text is missing from Fig. 3 (Fig. 1).[1] 
In the press release reporting the study findings, neither Dr 
Elizabeth G Nabel, the former Director of the National Heart, Lung, 
and Blood Institute nor Dr Jacques Rossouw, the project leader, 
mentioned this result. Dr Nabel is reported to have said: ‘The results 
of this study do not change established recommendations on disease 
prevention. Women should continue to … work with their doctors to 
reduce their risks for heart disease including following a diet low in 
saturated fat, trans fat and cholesterol’.[2]
The project leader’s opinion was: ‘This study shows that just reducing 
total fat intake does not go far enough to have an impact on heart 
disease risk. While the participants’ overall change in [low-density 
lipoprotein (LDL)] ‘bad’ cholesterol was small, we saw trends towards 
greater reductions in cholesterol and heart disease risk in women 
eating less saturated and trans fat’.[2] However, this explanation is false 
for three reasons.
First, the prognosis of women with diagnosed CVD worsened 
when they ate the ‘heart healthy’ low-fat diet that would produce 
‘favourable’ changes in ‘bad’ cholesterol. Second, the focus of this 
uniquely expensive study was to measure outcomes, not changes in 
biological markers. The latter could have been done with a far less 
expensive trial. Third, the project leader’s statement confirms that the 
WHIRCMDT was not designed to test a null hypothesis. Instead, the 
inconvenient finding supporting the null hypothesis was promoted 
as evidence for a false-negative finding on the grounds that the 
intervention did ‘not go far enough’.
In fact, there were a number of negative findings from the 
WHIRCDMT. The leanest women at the start of the trial gained 
weight on the low-fat diet[3] and those with the least insulin resistance 
at the start of the trial were at greater risk of developing type 2 
diabetes mellitus (DM) if assigned to the low-fat diet.[4] The low-
fat diet also worsened glucose control in women with diagnosed 
diabetes,[5] a finding that ‘agrees with some, but not all, previous 
studies evaluating the effects of high- and low-carbohydrate diets in 
persons with diabetes’ (p. 83).[1] The authors concluded: ‘… caution 
should be exercised in recommending a reduction in overall dietary 
fat in women with diabetes unless accompanied by additional 
recommendations to guide carbohydrate intake’ (p. 84).[1] 
In fact, these studies neatly disprove the diet-heart hypothesis 
since adoption of ‘heart healthy’ eating not only failed to influence 
future cardiac events in the healthy but it increased such events in the 
unhealthy and worsened diabetic control in those with type 2 DM.
The recently (February 2013) recovered data from the Sydney Diet 
Heart Study[6] confirm that a key component of the ‘healthy heart’ diet 
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– replacing dietary saturated fatty acids (SFA) with polyunsaturated 
fatty acids (PUFA), specifically n-6 PUFA linoleic acid – ‘increased 
rates of death from cardiovascular disease, coronary heart disease 
and all cause mortality compared to a control diet rich in SFA from 
animal fats and common margarines’ (p. 4).[6] As in the WHIRCDMT, 
the active intervention produced adverse outcomes even though it 
lowered blood cholesterol concentrations. Analysis of all published 
trials of primary and secondary interventions with n-6 PUFA linoleic 
acid confirms adverse outcomes approaching statistical significance 
(p. 4).[6] The mechanisms by which oxidised omega-6 PUFA may 
initiate and promote atherosclerosis is understood.[6] In contrast, n-3 
PUFAs (from fish, certain vegetables and pasture-raised ruminants) 
appear protective. 
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Fig. 1. Extracted from Howard et al.[1] (Fig. 3). The figure compares the coronary heart disease (CHD) outcome in the intervention (low-fat ‘heart healthy’ 
eating) and comparison (usual eating) groups according to 15 different variables, 2 of which are shown here. Note that for statin use there are 2 lines of 
information indicating either use (Yes) or non-use (No) of statins. But for the ‘history of cardiovascular disease (CVD)’ group there is a missing line of text 
for those women with CVD at the start of the trial (Yes). Note that the hazard ratio (HR) for the missing Yes line favours the usual eating, comparison group 
indicating that women with CVD at the start of the trial had a more favourable outcome if they did not adopt the low-fat ‘heart healthy’ diet. This is the only 
significant finding reported in that paper. MI = myocardial infarction; CABG = coronary artery bypass graft; PCI = percutaneous coronary intervention.
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